Lung malignancy in prostate cancer: A report of both metastatic and primary lung lesions

Lung malignancy in prostate cancer: A report of both metastatic and primary lung lesions

Bibliographic Details
Main Authors:	Lael Reinstatler, Jonathan Dupuis, Jessica L. Dillon, Candice C. Black, Joseph D. Phillips, Elias S. Hyams
Format:	Article
Language:	English
Published:	Elsevier 2018-01-01
Series:	Urology Case Reports
Subjects:	Prostate cancer Metastatic prostate cancer Pulmonary metastases
Online Access:	http://www.sciencedirect.com/science/article/pii/S221444201730342X

Similar Items

A case report of a prostate cancer metastasis in the pancreas exhibiting vascular encasement
by: Lauren Phung, BS, et al.
Published: (2024-03-01)

Impact of Extraskeletal Metastases on Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer with Bone Metastases
by: Soraia Lobo-Martins, et al.
Published: (2020-07-01)

A Novel Radiographic Pattern Related to Poor Prognosis in Patients with Prostate Cancer with Metastatic Spinal Cord Compression
by: Johan Wänman, et al.
Published: (2023-02-01)

Metastatic prostate cancer presenting as interstitial lung disease
by: Gupta Shweta, et al.
Published: (2012-01-01)

The Current Therapeutic Landscape for Metastatic Prostate Cancer
by: Anastasia Bernal, et al.
Published: (2024-03-01)

Recent Scientific Developments in Metastatic Prostate Cancer
by: Isabel Heidegger
Published: (2020-11-01)

Regional location of lymph node metastases predicts survival in patients with de novo metastatic prostate cancer
by: Zhi-Peng Wang, et al.
Published: (2023-01-01)

Real-world prostate-specific antigen reduction and survival outcomes of metastatic hormone-sensitive prostate cancer patients treated with apalutamide: An observational, retrospective, and multicentre study
by: Alicia López-Abad, et al.
Published: (2024-03-01)

Case report: Robotically visualized and biopsy-confirmed peritoneal carcinomatosis as initial identification of metastatic prostate adenocarcinoma in a patient with a history of prostatic urethral lift
by: Qateeb Khan, et al.
Published: (2024-01-01)

Case Report: Tumor-to-tumor metastasis with prostate cancer metastatic to lung cancer: the first reported case
by: Shiyue Liu, et al.
Published: (2023-08-01)

Health-related quality of life of metastatic prostate cancer patients treated with prostate Radiotherapy
by: Heba Maged Ayoub, et al.
Published: (2023-10-01)

Radium-223 in metastatic castration resistant prostate cancer
by: Winston Vuong, et al.
Published: (2014-06-01)

Prolonged Remission of Prostate Cancer Presenting as Endobronchial Metastases Following Total Androgen Blockade: A Case Report and Literature Review
by: Robert S. Freund, et al.
Published: (2019-09-01)

Efficacy of enzalutamide in patients with metastatic hormone-sensitive and castration-refractory prostate cancer: authors’ experience
by: T. V. Ustinova, et al.
Published: (2021-12-01)

Ethnicity and insurance status predict metastatic disease presentation in prostate, breast, and non‐small cell lung cancer
by: Nima Aghdam, et al.
Published: (2020-08-01)

Prevalence and Prognostic Implications of PSA Flares during Radium-223 Treatment among Men with Metastatic Castration Resistant Prostate Cancer
by: Amanjot Sidhu, et al.
Published: (2023-08-01)

Megestrol Acetate for Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer: An Old Answer for a New Problem
by: Maria La Vecchia, et al.
Published: (2022-03-01)

Treatment Landscape for Metastatic Castrate-Sensitive Prostate Cancer: A Review
by: Meagher MF, et al.
Published: (2023-11-01)

Role of chemotherapy in prostate cancer
by: Rita Nader, et al.
Published: (2018-01-01)

Outcomes of patients older than 75 years with non-metastatic prostate cancer
by: Yoshiyasu Amiya, et al.
Published: (2017-04-01)

The Continuum of Metastatic Prostate Cancer: Interpreting PSMA PET Findings in Recurrent Prostate Cancer
by: Adam M. Kase, et al.
Published: (2022-03-01)

Epithelial and Stromal Characteristics of Primary Tumors Predict the Bone Metastatic Subtype of Prostate Cancer and Patient Survival after Androgen-Deprivation Therapy
by: Pernilla Wikström, et al.
Published: (2022-10-01)

Impact of body mass index on clinico-pathological parameters and outcome in patients with metastatic prostate cancer
by: Amrallah A. Mohammed, et al.
Published: (2015-09-01)

Treatment Landscape for Patients with Castration-Resistant Prostate Cancer: Patient Selection and Unmet Clinical Needs
by: Turco F, et al.
Published: (2022-09-01)

Time to Castration Resistance as a Predictor of Response to Docetaxel in Metastatic Castration Resistance in Prostate Cancer
by: İlkay Gültürk, et al.
Published: (2022-11-01)

Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potential
by: Eric T. Miller, et al.
Published: (2020-05-01)

Prostate Cancer in Transplant Receivers—A Narrative Review on Oncological Outcomes
by: Karolina Hanusz, et al.
Published: (2023-10-01)

Traditional and novel imaging modalities for advanced prostate cancer: A critical review
by: Spencer Hill, et al.
Published: (2023-01-01)

LU-177-PSMA TREATMENT FOR METASTATIC PROSTATE CANCER – CASE EXAMPLES OF MIRACLE RESPONSES
by: K. Kairemo, et al.
Published: (2018-03-01)

Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase
by: Hui-Ming Lin, et al.
Published: (2021-10-01)

Oncological Response and Predictive Biomarkers for the Checkpoint Inhibitors in Castration-Resistant Metastatic Prostate Cancer: A Systematic Review and Meta-Analysis
by: Omar Fahmy, et al.
Published: (2021-12-01)

Prostate cancer involving bilateral seminal vesicles along with bone and testicular metastases: a case report
by: Qingqiang Gao, et al.
Published: (2018-03-01)

Body composition and metastatic prostate cancer survivorship
by: Adriana M Coletta, et al.
Published: (2021-01-01)

Case report: Exceptional and durable response to Radium-223 and suspension of androgen deprivation therapy in a metastatic castration-resistant prostate cancer patient
by: Francesca Zacchi, et al.
Published: (2024-03-01)

Efficacy of Treatment for Metastatic Hormone-Sensitive Prostate Cancer: An Umbrella Review of Systematic Reviews and Meta-Analyses
by: Pokket Sirisreetreerux, et al.
Published: (2023-12-01)

Validation of Cell-Free RNA and Circulating Tumor Cells for Molecular Marker Analysis in Metastatic Prostate Cancer
by: Michael Ladurner, et al.
Published: (2021-08-01)

Abiraterone acetate for early stage metastatic prostate cancer: patient selection and special considerations
by: Castellan P, et al.
Published: (2018-12-01)

POSSIBILITIES OF RADIUM-223 APPLICATION IN THERAPY OF PROSTATE GLAND CANCER
by: A. A. GRITSKEVICH, et al.
Published: (2017-06-01)

Ureteral metastasis from locally invasive, castrate-resistant prostate cancer: a case report
by: Zachary C. Janatpour, et al.
Published: (2021-11-01)

Advanced PSMA-PET/CT Imaging Parameters in Newly Diagnosed Prostate Cancer Patients for Predicting Metastatic Disease
by: Yaniv Yechiel, et al.
Published: (2023-02-01)